US Patent Issued to BioNTech, TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz on Sept. 9 for "Tumor antigens for determining cancer therapy" (German Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,221, issued on Sept. 9, was assigned to BioNTech SE (Mainz, Germany) and TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz (Mainz, Germany).

"Tumor antigens for determining cancer therapy" was invented by Ugur Sahin (Mainz, Germany), Claudia Paret (Mainz, Germany), Kirsten Vormbrock (Mainz, Germany), Christian Bender (Mainz, Germany), Petra Simon (Mainz, Germany), Christoph Hartmann (Frankfurt, Germany), Stefanie Hubich (Mainz, Germany), Thomas Bukur (Mainz, Germany) and Thorsten Litzenberger (Olsbrucken, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the treat...